Basics India Globalization Capital, Inc. India Globalization Capital Inc is engaged in the development of cannabis-based combination therapies to treat Alzheimer's, pain, nausea, eating disorders, several endpoints of Parkinson's, and epilepsy in humans, dogs, and cats. IPO Date: June 1, 2006 Sector: Industrials Industry: Trading Companies and Distributors Market Cap: $26.1M Activated in VL: True Average Daily Range Avg Daily Range: $0.08 | 5.49% Avg Daily Range (30 D): $0.01 | 2.55% Avg Daily Range (90 D): $0.01 | 3.75% Institutional Daily Volume Avg Daily Volume: .78M Avg Daily Volume (30 D): .18M Avg Daily Volume (90 D): .26M Trade Size Avg Trade Size (Sh.): 381 Avg Trade Size (Sh.) (30 D): 618 Avg Trade Size (Sh.) (90 D): 617 Institutional Trades Total Inst.Trades: 85 Avg Inst. Trade: $2.55M Avg Inst. Trade (30 D): $M Avg Inst. Trade (90 D): $M Avg Inst. Trade Volume: .23M Avg Inst. Trades (Per Day): 1 Market Closing Trades Avg Closing Trade: $1.15M Avg Closing Trade (30 D): $M Avg Closing Trade (90 D): $M Avg Closing Volume: 473.34K         News Jul 6, 2023 @ 12:03 PM Why VBI Vaccines Are Trading Lower By Over 23%; He... Source: Lisa Levin Mar 20, 2023 @ 12:45 PM IGC Announces Rebranding, Changes Name to IGC Pha... Source: IGC Pharma, Inc. Feb 15, 2023 @ 12:41 AM IGC Reports Financial Results for Third Fiscal Qua... Source: INDIA GLOBALIZATION CAPITAL INC. Feb 8, 2023 @ 1:30 PM IGC to be Featured in Feb. 10 Radius Research Inve... Source: INDIA GLOBALIZATION CAPITAL INC. Dec 20, 2022 @ 1:30 PM IGC Announces Updated Life Sciences Presentation Source: INDIA GLOBALIZATION CAPITAL INC. Financials   TTM Q2 2025 Q1 2025 Basic EPS $-.02 $-.04 Diluted EPS $-.02 $-.04 Revenue $ 1.18M $ .41M $ .27M Gross Profit $ .67M $ .2M $ .16M Net Income / Loss $ -12.57M $ -1.72M $ -2.38M Operating Income / Loss $ -9.32M $ -1.76M $ -2.4M Cost of Revenue $ .52M $ .21M $ .11M Net Cash Flow $ -1.47M $ $ PE Ratio     Splits Apr 19, 2013:   1:10